| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |